Rodgers Converts 220,114 Enovix Warrants; Trusts Hold Major Stakes (ENVX)
Rhea-AI Filing Summary
Thurman J. Rodgers, a director and reported >10% owner of Enovix Corporation (ENVX), reported exercising 220,114 publicly-traded warrants into common stock at an $8.75 exercise price, with the resulting shares held by a charitable trust for which he is trustee. The filing shows 1,120,114 shares beneficially owned following the transaction in that trust and an additional 20,858,407 shares held indirectly by a separate revocable trust. The revocable trust also holds 2,914,466 warrants. The report notes 22,543 restricted stock units outstanding for the reporting person. The warrants were distributed by the issuer at no cost and expire on October 1, 2026.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider exercised warrants for 220,114 shares; meaningful indirect trust holdings and warrants indicate concentrated ownership.
The filing documents a warrant exercise that converted 220,114 warrants into common shares at an $8.75 exercise price, increasing shares held in a trust controlled by the reporting person. Separately, a revocable trust controlled by the reporting person holds 20,858,407 shares and 2,914,466 warrants, which represents sizeable indirect exposure to Enovix equity and potential further dilution if exercised. The disclosure is routine but material to ownership structure and potential future supply of shares from outstanding warrants.
TL;DR: Transaction appears procedural; trustee status drives beneficial ownership disclosures and concentration of voting power.
The report clarifies that shares and warrants are held in trusts for which the reporting person is trustee and has voting and dispositive power. That trustee relationship is the key governance detail: it aggregates control and requires clear disclosure under Section 16. The filing also documents 22,543 RSUs tied to the reporting person, which are typical compensation-related contingent shares requiring future reporting upon settlement.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| X | Warrant (Right to Buy) | 220,114 | $0.00 | -- |
| X | Common Stock | 220,114 | $8.75 | $1.93M |
| holding | Warrant (Right to Buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Reflects shares issued upon the exercise of publicly-traded warrants (the "Warrants") by the Rodgers Family Freedom and Free Markets Charitable Trust for which the Reporting Person is a trustee and has voting and dispositive power over the shares and the Warrants. The Warrants were distributed by the Issuer on July 21, 2025 at no cost to the Reporting Person, and each Warrant entitles the holder to purchase one share of common stock at an exercise price of $8.75 per share in accordance with the Warrant Agreement dated July 21, 2025 between the Issuer and Computershare Trust Company N.A., as warrant agent (the "Warrant Agreement"). The shares and Warrants are held by the Rodgers Family Freedom and Free Markets Charitable Trust for which the Reporting Person is a trustee and has voting and dispositive power over the shares and Warrants. The shares and Warrants are held by the Rodgers Massey Revocable Living Trust dtd 4/4/11 for which the Reporting Person is a trustee and has voting and dispositive power over the shares and Warrants. Includes 22,543 shares issuable upon the settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The Warrants will expire and cease to be exercisable at 5:00 p.m. New York City time on October 1, 2026 (the "Expiration Date"). The Expiration Date is subject to automatic acceleration upon satisfaction of the early expiration price condition (as defined in the Warrant Agreement) and subject to the other terms of the Warrant Agreement. The Warrants were distributed by the Issuer on July 21, 2025 at no cost to the Reporting Person, and each Warrant entitles the holder to purchase one share of common stock at an exercise price of $8.75 per share in accordance with the Warrant Agreement.
